Ibuprofen-13C, d3
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Ibuprofen-13C, d3
Description :
Ibuprofen-13C, d3 is the 13C- and deuterium labeled Ibuprofen. Ibuprofen is an anti-inflammatory agent targeting COX-1 and COX-2 with IC50s of 13 μM and 370 μM, respectively[1].Product Name Alternative :
(±) -Ibuprofen-13C, d3UNSPSC :
12352005Hazard Statement :
H302Target :
Apoptosis; COX; Isotope-Labeled Compounds; ParasiteType :
Isotope-Labeled CompoundsRelated Pathways :
Anti-infection; Apoptosis; Immunology/Inflammation; OthersApplications :
COVID-19-immunoregulationField of Research :
Inflammation/Immunology; CancerSolubility :
10 mM in DMSOSmiles :
OC(C(C1=CC=C(C=C1)CC(C)C)[13C]([2H])([2H])[2H])=OMolecular Formula :
C12 13CH15D3O2Molecular Weight :
210.29Precautions :
P264-P270-P330-P501References & Citations :
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-223.|[2]Driban JB, et al. Joint inflammation and early degeneration induced by high-force reaching are attenuated by ibuprofen in an animal model of work-related musculoskeletal disorder. J Biomed Biotechnol. 2011;2011:691412|[3]Khwaja F, et al. Ibuprofen inhibits survival of bladder cancer cells by induced expression of the p75NTR tumor suppressor protein. Cancer Res. 2004 Sep 1;64 (17) :6207-13.|[4]Noreen Y, et al. Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis. J Nat Prod. 1998 Jan;61 (1) :2-7.|[5]Palayoor ST, et al. Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene. 1999 Dec 2;18 (51) :7389-94.|[6]Rao GH, et al. Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin. Arteriosclerosis. 1983 Jul-Aug;3 (4) :383-8.Shipping Conditions :
Room temperatureScientific Category :
Isotope-Labeled CompoundsClinical Information :
No Development ReportedCAS Number :
[1261394-40-4]

